Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07237737 · ClinicalTrials.gov registry record · NA
Alexis Retractor in Total Hip Arthroplasty
A NA study, sponsored by University of Miami.
- Not yet
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT07237737 is a NA study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 202 participants.
The verdict
NCT07237737, a NA study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.
Interventions
- DEVICE Alexis wound retractor
- DEVICE Standard wound retractor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2026-12 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07237737
The ClinicalTrials.gov registry entry for NCT07237737 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alexis wound retractor is the first listed.
NCT07237737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07237737 about?
NCT07237737 is a clinical study titled "Alexis Retractor in Total Hip Arthroplasty". To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.
What is the current status of trial NCT07237737?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 202 participants. The study started on 2026-12. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07237737?
The interventions under investigation include: Alexis wound retractor (DEVICE), Standard wound retractor (DEVICE).
Who is sponsoring clinical trial NCT07237737?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.